Locations:

Tag: asco21

Metastatic melanoma cells. Image source: National Cancer Institute

June 9, 2021/Cancer/Tumor Oncology

Adjuvant Pembrolizumab Improves Relapse-Free Survival in Patients with High-Risk Resected Melanoma

Overall survival benefit not established

June 8, 2021/Cancer

New Drug Holds Promise for Rare Neuroendocrine Tumors

Data from Phase 2 study of ONC201 to be presented at ASCO

June 7, 2021/Cancer/Genomics

New Polygenic Risk Score for Breast Cancer Accurate for All Ancestries

Improved risk stratification for all women

Case Study in Collaboration: Decreasing Prolonged Post-CABG Ventilation Rates

June 4, 2021/Cancer/Research

Mechanical Ventilation Rates in Oncology Patients with COVID-19

Low rates raise questions about eligibility for intervention

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

June 4, 2021/Cancer/Genomics

Inherited Risk of Estrogen-Driven Postmenopausal Breast Cancer

Adrenal-permissive HSD3B1 plays a role

BackPage 1 of 1Next